Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

EBR Systems Reports Implant Shortfall as September Activity Halves

EBR: $0.165 +22.22% · MC: $113M

EBR Systems said third-quarter WiSE implant volumes fell below expectations, with September activity approximately half the average monthly level in July and August. The company is recruiting a new chief commercial officer and reported positive early results in the fourth quarter following a realignment of its US commercial team. Medicare reimbursement for eligible procedures has increased, while a proposed national coverage decision is expected in early December. EBR expects approval of its new manufacturing site by year-end, subject to FDA review, and held approximately A$137 million in cash and securities at the end of September after completing a A$150 million capital raising.

Source announcements: 2026-11-10 08:25 to 2026-11-10 10:58 Sydney time
Story updated 2026-11-10 11:03 Sydney time
SourcesQ3 2026 Quarterly Activity Report and Form 10-Q SubmissionInvestor WebinarInvestor Webinar - Updated
Comments